Lung Transplantation in Coronavirus-19 Patients: What We Have Learned So Far.
Lung Transplantation in Coronavirus-19 Patients: What We Have Learned So Far.
复制标题
DOI：
10.1016/j.ccm.2022.11.017
复制
发表时间：
2023-06
影响因子：
5.7
通讯作者：
Bharat, Ankit
中科院分区：
文献类型：
--
作者：
Cerier, Emily;Lung, Kalvin;Kurihara, Chitaru;Bharat, Ankit
冠状病毒-19 (COVID-19) 可导致不可恢复的急性呼吸窘迫综合征 (ARDS) 或限制生命的纤维化，肺移植是目前唯一可行的治疗方法。 COVID-19 肺移植改变了肺移植领域，与大流行之前一样，在传染病或 ARDS 的情况下进行的移植很少。鉴于与 COVID-19 肺移植相关的复杂性，需要在资源丰富的医院环境中由经验丰富的多学科团队进行严格的患者选择。目前 COVID-19 肺移植的短期结果是有希望的。然而，需要进行后续研究来确定长期结果以及这些患者是否容易出现独特的并发症。
Coronavirus-19 (COVID-19) can result in irrecoverable acute respiratory distress syndrome (ARDS) or life-limiting fibrosis for which lung transplantation is currently the only viable treatment. COVID-19 lung transplantation has transformed the field of lung transplantation, as before the pandemic, few transplants had been performed in the setting of infectious disease or ARDS. Given the complexities associated with COVID-19 lung transplantation, it requires strict patient selection with an experienced multidisciplinary team in a high-resource hospital setting. Current short-term outcomes of COVID-19 lung transplantation are promising. However, follow-up studies are needed to determine long-term outcomes and whether these patients may be predisposed to unique complications.
登录
查看更多内容
影响因子：
4.6
作者：
Bermudez, Christian A.;Shiose, Akira;Pilewski, Joseph M.
通讯作者：
Pilewski, Joseph M.
DOI：
10.1016/s2213-2600(21)00383-0
发表时间：
2021-11
期刊：
The Lancet. Respiratory medicine
影响因子：
--
作者：
Evans RA;McAuley H;Harrison EM;Shikotra A;Singapuri A;Sereno M;Elneima O;Docherty AB;Lone NI;Leavy OC;Daines L;Baillie JK;Brown JS;Chalder T;De Soyza A;Diar Bakerly N;Easom N;Geddes JR;Greening NJ;Hart N;Heaney LG;Heller S;Howard L;Hurst JR;Jacob J;Jenkins RG;Jolley C;Kerr S;Kon OM;Lewis K;Lord JM;McCann GP;Neubauer S;Openshaw PJM;Parekh D;Pfeffer P;Rahman NM;Raman B;Richardson M;Rowland M;Semple MG;Shah AM;Singh SJ;Sheikh A;Thomas D;Toshner M;Chalmers JD;Ho LP;Horsley A;Marks M;Poinasamy K;Wain LV;Brightling CE;PHOSP-COVID Collaborative Group
通讯作者：
PHOSP-COVID Collaborative Group
影响因子：
17.1
作者：
Bharat A;Querrey M;Markov NS;Kim S;Kurihara C;Garza-Castillon R;Manerikar A;Shilatifard A;Tomic R;Politanska Y;Abdala-Valencia H;Yeldandi AV;Lomasney JW;Misharin AV;Budinger GRS
通讯作者：
Budinger GRS
影响因子：
10
作者：
Hui, DS;Joynt, GM;Sung, JJY
通讯作者：
Sung, JJY
影响因子：
8.9
作者：
Chambers, Daniel C.;Cherikh, Wida S.;Stehlik, Josef
通讯作者：
Stehlik, Josef